STOCK TITAN

Insider plans 60,000 share sale (NASDAQ: XERS) under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider has filed a Form 144 indicating an intention to sell 60,000 shares of common stock of issuer XERS through Morgan Stanley Smith Barney LLC on or around 01/08/2026, with the shares listed on the NASDAQ. The filing cites an aggregate market value of $432,600.00 for this planned sale.

The shares to be sold were acquired as restricted stock units from the issuer on 01/31/2021. As context, the filing notes that there were 165,924,289 shares of this class outstanding.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for XERS disclose?

The Form 144 discloses that an insider intends to sell 60,000 shares of XERS common stock, with an aggregate market value of $432,600.00, under Rule 144.

When are the XERS shares expected to be sold under this Form 144?

The filing lists an approximate date of sale of 01/08/2026 for the planned sale of 60,000 XERS common shares on the NASDAQ.

How were the 60,000 XERS shares in the Form 144 acquired?

The 60,000 shares were acquired as restricted stock units from the issuer on 01/31/2021, with the same date shown as the payment date and the nature of payment noted as N/A.

What is the role of the broker in this XERS Form 144 filing?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker to handle the planned sale of 60,000 XERS common shares on the NASDAQ.

How many XERS shares of this class are outstanding according to the Form 144?

The Form 144 notes that there are 165,924,289 shares of the relevant class of XERS common stock outstanding.

Does the XERS Form 144 mention recent sales in the past three months?

The excerpt includes a section for securities sold during the past 3 months, but no specific past sales data is provided in the available content.
Xeris Biopharma Holdings

NASDAQ:XERS

XERS Rankings

XERS Latest News

XERS Latest SEC Filings

XERS Stock Data

1.25B
159.39M
4.05%
56.89%
9.11%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO